Skip to content
2000
Volume 2, Issue 11
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Since the start of the decade, the coronavirus disease 2019 [COVID-19] pandemic has disrupted the world's healthcare system. Scientists have been engaged to bring about a therapeutic agent to help combat the dreaded disease. Many researchers have shown antivirals such as Remdesivir and Favipiravir to be effective in the treatment; however, these drugs have a short half-life. Hence, the need for a drug delivery system that could prolong or alter their effect by increasing the potency of antivirals or vaccines has been proposed. Nanotechnology has always been at the forefront of developing and diagnosing diseases. The idea of which can be borrowed to treat the novel coronavirus. The applicability needs to be vast as the disease has spread, and a fast, reliable, effective therapeutic and diagnostic procedure is the need of the hour. Emphasis on nanotechnology usage through the intranasal and pulmonary route has been given and various applications have also been discussed in this review.

Loading

Article metrics loading...

/content/journals/covid/10.2174/2666796702666210122123141
2021-11-01
2024-11-08
Loading full text...

Full text loading...

/content/journals/covid/10.2174/2666796702666210122123141
Loading


  • Article Type:
    Review Article
Keyword(s): antiviral; coronavirus; COVID-19; diagnosis; nanotechnology; vaccine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test